Left Ventricular Hypertrophy as A Surrogate End-Point in Hypertension

References

• Levy D., Garrison R. J., Savage D. D., Kannel W. B., Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 322: 1561–1566
   PubMed Web of Science ®Google Scholar
• Bikkina M., Levy D., Evans JC, et al. Left ventricular mass and the risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA 1994; 272: 33–36
   PubMed Web of Science ®Google Scholar
• Keren M. J., Devereux R. B., Casale P. N., Savage D. D., Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114: 345–352
   PubMed Web of Science ®Google Scholar
• Mensah G. A., Pappas T. W., Koren M. J., Ulin R. J., Laragh J. H., Devereux RB. Comparison of classification of hypertension severity by blood pressure level and World Health Organization criteria for prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension. J Hypertens. 1993; 11: 1433–1444
   Google Scholar
• Bolognese L., Dellavese P., Rossi L., Sarasso G., Bongo A. S., Scianaro MC. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. Am J Cardiol. 1994; 73: 1–5
   PubMed Web of Science ®Google Scholar
• Liao Y., Cooper R. S., McGee D. L., Mensah G. A., Ghali JK. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 1995; 273: 1592–1597
   PubMed Web of Science ®Google Scholar
• Liao Y., Cooper R. S., Durazu-Arvizu R., Mensah G. A., Ghali JK. Prediction of mortality risk by different methods of indexing for left ventricular mass. J Am Coll Cardiol. 1997; 29: 641–647
   PubMed Web of Science ®Google Scholar
• Koren M. J., Ulin R. J., Laragh J. H., Devereux RB. Reduction of left ventricular mass during treatment of essential hypertension is associated with improved prognosis. Am J Hypertens. 1991; 4: 1
   PubMedGoogle Scholar
• Yurenev A. P., Dyakonova H. G., Novikov I. D., et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trialAm J Hypertens 1992; 5: 182s–189s
   PubMed Web of Science ®Google Scholar
• Levy D., Salomon M., D'Agostino R. B., Belanger A. J., Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90: 1786–1793
   PubMed Web of Science ®Google Scholar
• Muiesan M. L., Salvetti M., Rizzoni D., Castellano M., Donato F., Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens. 1995; 13: 1091–1105
   PubMed Web of Science ®Google Scholar
• Verdecchia P., Schillaci G., Borgioni C., et al. Prognostic value of serial changes in left ventricular mass in essential hypertension. (Abstr). Am J Hypertens. 1997; 10: 25
   Google Scholar
• Devereux R. B., Agabiti-Rosei E., Dahlof B., et al. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. J Hypertens 1996; 14((Suppl 2))s95–s102
   Google Scholar
• Devereux R. B., Okin P. M., Roman MJ. Preclinical cardiovascular disease and surrogate end-points in hypertension: does race influence target organ damage independent of blood pressure?. Ethnicity Dis 1998; 8: 138–148
   PubMedGoogle Scholar
• Sutherland J. E., Gazes P. C., Keil J. E., Gilbert G. E., Knapp RG. Electrocardiographic abnormalities and 30-year mortality among white and black men of the Charleston Heart Study. Circulation 1993; 88: 2685–2692
   PubMed Web of Science ®Google Scholar
• Breslin D. J., Gifford RW, Jr., Fairbairn JFII. Essential hypertension: a twenty year follow-up study. Circulation 1966; 33: 87–97
   PubMed Web of Science ®Google Scholar
• Sokolow M., Perloff D. Prognosis of essential hypertension treated conservatively. Circulation 1961; 23: 697–713
   Web of Science ®Google Scholar
• Sullivan J. M., Vander Zwaag R., El-Zecky F., Ramanathan K. B., Mirvis DM. Left ventricular hypertrophy: Effect on survival. J Am Coll Cardiol. 1993; 22: 508–513
   PubMed Web of Science ®Google Scholar
• Kannel W. B., Abbott RD. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction. Am Heart J. 1986; 111: 391–397
   PubMed Web of Science ®Google Scholar
• MacMahon S., Collins G., Rautaharju P., et al. for the Multiple Risk Factor Intervention Trial Research Group. Electrocardiographic left ventricular hypertrophy and effects of drug therapy in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1989; 6: 202–210
   Google Scholar
• Isles C. G., Walker L. V., Beevers D. G., et al. Mortality in the Glasgow blood pressure clinic. J Hypertens. 1987; 4: 141–156
   Web of Science ®Google Scholar
• Casale P. N., Devereux R. B., Milner M., et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986; 105: 173–178
   PubMed Web of Science ®Google Scholar
• Levy D., Garrison R. J., Savage D. D., Kannel W. B., Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: The Framingham Study. Ann Intern Med. 1989; 110: 101–108
   PubMed Web of Science ®Google Scholar
• Quinones M. A., Weiner D. H., Shelton B. J., et al. for the SOLVD Investigators: Echocardiographic predictors of one-year clinical outcome in the Study of Left Ventricular Dysfunction (SOLVD) Trial and Registry: A study of 1,172 patients, (abstr). Circulation 1993; 90: I–304, (Suppl I)
   Google Scholar
• Silberberg J. S., Barre P. E., Prichard S. S., Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989; 36: 286–290
   PubMed Web of Science ®Google Scholar
• Parfrey P. S., Harnett J. D., Griffiths S. M., et al. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron. 1990; 55: 114–120
   PubMed Web of Science ®Google Scholar
• Aronow W. S., Epstein S., Koenigsberg M., Schwartz KS. Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden death in elderly patients. Am J Cardiol. 1988; 62: 1124–1125
   PubMed Web of Science ®Google Scholar
• Koren M. J., Savage D. D., Casale P. N., Laragh J. H., Devereux RB. Changes in left ventricular mass predict risk in essential hypertension. Circulation 1990; 82: III–29., (Suppl III)
   Google Scholar
• Devereux R. B., Alonso D. R., Lutas E. M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57: 450–458
   PubMed Web of Science ®Google Scholar
• de Yurenev A. P., Quattro V., Devereux RB. Hypertensive heart disease: Relationship of silent ischemia to coronary artery disease and left ventricular hypertrophy. Am Heart J. 1990; 120: 928–933
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Dahlof B. Requirements for an informative trial of left ventricular hypertrophy regression. J Hum Hypertens. 1994; 8: 735–739
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Dahlof B., Levy D., Pfeffer MA. Comparison of enalapril vs nifedipine to decrease left ventricular hypertrophy in systemic hypertension (The PRESERVE Trial). Am J Cardiol. 1996; 78: 61–65
   PubMed Web of Science ®Google Scholar
• Dahlof B., Devereux R., de Faire U., et al. The Losartan Intervention for Endpoint reduction (LIFE) Study in Hypertension. Rationale, design and methods. Am J Hypertens. 1997; 10: 705–713
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Bella M. J., Dahlof B., Gerdts E., Niemenen M., Nielsen J. Papademetriou V for the LIFE Study Group: Left ventricular geometry and function in hypertensive patients with ECG left ventricular hypertrophy: The LIFE Trial. J Am Coll Cardiol 1998; 31: 376A.
   Google Scholar
• Bond G., et al. ELSA (European Lacidipine Study on Atherosclerosis). J Cardiovasc Pharmacol. 1994; 23: s85–s87, (Suppl 5)
   Google Scholar
• Liebson P. R., Grandits G., Prineas R., et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993; 87: 476–486
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to clinical morbid event. Circulation 1993; 88: 1444–1455
   PubMed Web of Science ®Google Scholar